Regeneron Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
If you are employed by Regeneron Pharmaceuticals Inc and you would like to use your ESG aseessment, please get in touch. The analysis of Regeneron Pharmaceuticals Inc is assembled by All Street Sevva using leading AI. Scroll down to the bottom of this page for potential risks for Regeneron Pharmaceuticals Inc based on sector, geography and marketcap.
Regeneron Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 6.0, social score of 8.0 and governance score of 1.1.
5.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 724 | Skye Bioscience Inc | 5.1 | High |
| 724 | Xbrane Biopharma AB | 5.1 | High |
| 744 | Regeneron Pharmaceuticals Inc | 5.0 | High |
| 744 | CSL Ltd | 5.0 | High |
| 744 | CStone Pharmaceuticals | 5.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Regeneron Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Regeneron Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Regeneron Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Regeneron Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Regeneron Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Regeneron Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Regeneron Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.